FDA.reportPublic FDA data

atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet

RxCUI
1046997
RxNorm name
atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet
Display name
Atropine/Hyoscyamine/PHENobarbital/Scopolamine XR (Oral Pill)
Full name
atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet
Term type
SCD
Status
Active
Strength
0.0582-0.311-48.6-0.0195 mg
Dose form
XR Tab
Route
Oral Pill
Updated
2026-08-03 17:29:52

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122010
Active start
122010
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
atropine sulfate0.0582 MG / 1 EACHatropineatropine sulfate
hyoscyamine sulfate0.311 MG / 1 EACHhyoscyaminehyoscyamine sulfate
phenobarbital48.6 MG / 1 EACHphenobarbitalphenobarbital
scopolamine hydrobromide0.0195 MG / 1 EACHscopolaminescopolamine hydrobromide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Extended Release Oral Tablet316945

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
atropine1223
hyoscyamine153970
phenobarbital8134
scopolamine9601

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRatropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / PHENobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral TabletNAMES
RxNorm Nameatropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral TabletNAMES
TTYSCDATTRIBUTES
RxCUI1046997CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 14 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00143214801rxnav_historical
00247050903rxnav_historical_indirect
00247050904rxnav_historical_indirect
00247050908rxnav_historical_indirect
00247050910rxnav_historical_indirect
00247050920rxnav_historical_indirect
00247050930rxnav_historical_indirect
00603241921rxnav_historical_indirect
55422080401rxnav_historical_indirect
60258080401rxnav_historical_indirect
60491021260rxnav_historical_indirect
60491021268rxnav_historical_indirect
66213042110rxnav_historical_indirect
66213042150rxnav_historical_indirect

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2064014b-6f8e-4232-88c2-d1870042abc7atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral TabletSCD1Donnatal Extentabs20111017
2064014b-6f8e-4232-88c2-d1870042abc7atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / PHENobarbital 48.6 MG / scopolamine HBr 0.0195 MG Extended Release Oral TabletPSN1Donnatal Extentabs20111017

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
48f317df-7ae5-4a80-8303-111e65767424National Council for Prescription Drug Programs20120724
f172a009-1973-4e35-899b-021b2a230d77National Council for Prescription Drug Programs20120724
2064014b-6f8e-4232-88c2-d1870042abc7Donnatal ExtentabsPBM Pharmaceuticals, Inc | West-ward Pharmaceutical Corp.20111017

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01FAAnticholinergicsATC1-4scopolamine
ATCS01FAAnticholinergicsATC1-4atropine
ATCN03AABarbiturates and derivativesATC1-4phenobarbital
ATCA03BABelladonna alkaloids, tertiary aminesATC1-4atropine
ATCA03BABelladonna alkaloids, tertiary aminesATC1-4hyoscyamine
ATCA04ADOther antiemeticsATC1-4scopolamine
ATCN05CMOther hypnotics and sedativesATC1-4scopolamine
FDASPLN0000175574AnticholinergicEPChas_epcscopolamine
FDASPLN0000175574AnticholinergicEPChas_epcatropine
FDASPLN0000175700Cholinergic Muscarinic AntagonistEPChas_epcatropine
FDASPLN0000175370Cholinergic AntagonistsMOAhas_moaatropine
FDASPLN0000175370Cholinergic AntagonistsMOAhas_moascopolamine
FDASPLN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moaatropine
MEDRTD001285AtropineCHEMhas_ingredientatropine
MEDRTD001285AtropineCHEMhas_ingredientatropine sulfate
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine sulfate
MEDRTD010634PhenobarbitalCHEMhas_ingredientphenobarbital
MEDRTD012601ScopolamineCHEMhas_ingredientscopolamine
MEDRTD012601ScopolamineCHEMhas_ingredientscopolamine hydrobromide
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine sulfate
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine
MEDRTD000402Airway ObstructionDISEASEci_withphenobarbital
MEDRTD000647AmnesiaDISEASEinducesscopolamine
MEDRTD000647AmnesiaDISEASEinducesscopolamine hydrobromide
MEDRTD001249AsthmaDISEASEci_withatropine
MEDRTD001249AsthmaDISEASEci_withatropine sulfate
MEDRTD001919BradycardiaDISEASEmay_treatatropine sulfate
MEDRTD001919BradycardiaDISEASEmay_treatatropine
MEDRTD003085ColicDISEASEmay_treathyoscyamine
MEDRTD003085ColicDISEASEmay_treathyoscyamine sulfate
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine sulfate
MEDRTD003093Colitis, UlcerativeDISEASEci_withatropine
MEDRTD003093Colitis, UlcerativeDISEASEci_withatropine sulfate
MEDRTD003108Colonic DiseasesDISEASEmay_treatscopolamine
MEDRTD003108Colonic DiseasesDISEASEmay_treatscopolamine hydrobromide
MEDRTD004238DiverticulitisDISEASEmay_treatscopolamine hydrobromide
MEDRTD004238DiverticulitisDISEASEmay_treatscopolamine
MEDRTD004342Drug HypersensitivityDISEASEci_withatropine sulfate
MEDRTD004342Drug HypersensitivityDISEASEci_withphenobarbital
MEDRTD004342Drug HypersensitivityDISEASEci_withscopolamine
MEDRTD004342Drug HypersensitivityDISEASEci_withscopolamine hydrobromide
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine sulfate
MEDRTD004342Drug HypersensitivityDISEASEci_withatropine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatatropine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatatropine sulfate
MEDRTD004403DysenteryDISEASEmay_treatscopolamine
MEDRTD004403DysenteryDISEASEmay_treatscopolamine hydrobromide
MEDRTD004828Epilepsies, PartialDISEASEmay_treatphenobarbital
MEDRTD020936Epilepsy, Benign NeonatalDISEASEmay_treatphenobarbital
MEDRTD004830Epilepsy, Tonic-ClonicDISEASEmay_treatphenobarbital
MEDRTD005158Facial ParalysisDISEASEmay_treatscopolamine
MEDRTD005158Facial ParalysisDISEASEmay_treatscopolamine hydrobromide
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine sulfate
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine sulfate
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withatropine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withscopolamine hydrobromide
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withscopolamine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withatropine sulfate
MEDRTD006323Heart ArrestDISEASEmay_treatatropine sulfate
MEDRTD006323Heart ArrestDISEASEmay_treatatropine
MEDRTD006327Heart BlockDISEASEci_withatropine
MEDRTD006327Heart BlockDISEASEci_withatropine sulfate
MEDRTD006470HemorrhageDISEASEci_withscopolamine
MEDRTD006470HemorrhageDISEASEci_withscopolamine hydrobromide
MEDRTD006932HyperbilirubinemiaDISEASEmay_treatphenobarbital
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine sulfate
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine sulfate
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine sulfate
MEDRTD007415Intestinal ObstructionDISEASEci_withatropine
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine
MEDRTD007415Intestinal ObstructionDISEASEci_withscopolamine
MEDRTD007415Intestinal ObstructionDISEASEci_withatropine sulfate
MEDRTD007415Intestinal ObstructionDISEASEci_withscopolamine hydrobromide
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine sulfate
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine
MEDRTD015863IridocyclitisDISEASEmay_treatscopolamine
MEDRTD015863IridocyclitisDISEASEmay_treatscopolamine hydrobromide
MEDRTD007499Iris DiseasesDISEASEci_withatropine
MEDRTD007499Iris DiseasesDISEASEci_withatropine sulfate
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine sulfate
MEDRTD007674Kidney DiseasesDISEASEci_withatropine
MEDRTD007674Kidney DiseasesDISEASEci_withatropine sulfate
MEDRTD007905Lens DiseasesDISEASEci_withatropine sulfate
MEDRTD007905Lens DiseasesDISEASEci_withatropine
MEDRTD008107Liver DiseasesDISEASEci_withatropine
MEDRTD008107Liver DiseasesDISEASEci_withatropine sulfate
MEDRTD017093Liver FailureDISEASEci_withphenobarbital
MEDRTD008532Megacolon, ToxicDISEASEci_withatropine sulfate
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine sulfate
MEDRTD008532Megacolon, ToxicDISEASEci_withatropine
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine
MEDRTD009041Motion SicknessDISEASEmay_preventscopolamine hydrobromide
MEDRTD009041Motion SicknessDISEASEmay_preventscopolamine
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine sulfate
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine
MEDRTD009157Myasthenia GravisDISEASEci_withatropine
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withscopolamine
MEDRTD009157Myasthenia GravisDISEASEci_withatropine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine
MEDRTD009157Myasthenia GravisDISEASEci_withscopolamine hydrobromide
MEDRTD015878MydriasisDISEASEinducesscopolamine hydrobromide
MEDRTD015878MydriasisDISEASEinducesscopolamine
MEDRTD015878MydriasisDISEASEinducesatropine
MEDRTD015878MydriasisDISEASEinducesatropine sulfate
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine sulfate
MEDRTD009325NauseaDISEASEmay_preventscopolamine hydrobromide
MEDRTD009325NauseaDISEASEmay_preventscopolamine
MEDRTD010301Parkinson Disease, PostencephaliticDISEASEmay_treatscopolamine
MEDRTD010301Parkinson Disease, PostencephaliticDISEASEmay_treatscopolamine hydrobromide
MEDRTD010437Peptic UlcerDISEASEmay_treathyoscyamine sulfate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.0582 MG / 0.311 MG / 48.6 MG / 0.0195 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESRxCUI1046997
NAMESPrescribable Synonymatropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / PHENobarbital 48.6 MG / scopolamine HBr 0.0195 MG Extended Release Oral Tablet
NAMESRXNAV_STRatropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / PHENobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet
NAMESRxNorm Nameatropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet
NAMESTallman Synonymatropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / PHENobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet